Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-κB and activator protein-1 in inflammatory acne lesions in vivo

American Journal of Pathology

Volumn 166, Issue 6, 2005, Pages 1691-1699

  Kang, Sewon ^a,c   Cho, Soyun ^a,b   Chung, Jin Ho ^a,b   Hammerberg, Craig ^a   Fisher, Gary J ^a   Voorhees, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROCOLLAGEN; STROMELYSIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACNE; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY;

EID: 19544382707     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62479-0     Document Type: Article

References (39)

1. Brown S, Shalita A: Acne vulgaris. Lancet 1998, 351:1871-1876
2. Kraning K, Odland G: Prevalence, morbidity, and cost of dermatological diseases. J Invest Dermatol 1979, 73:395-401
3. Koo J, Smith L: Psychologic aspects of acne. Pediatr Dermatol 1991, 8:185-188
4. Knutson D: Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol 1974, 62:288-307
5. Lavker R, Leyden J: Lamellar inclusions in follicular horny cells: a new aspect of abnormal keratinization. J Ultrastruct Res 1979, 69:362-370
6. Marples R, Leyden J, Stewart R, Mills O, Kligman A: The skin microflora in acne vulgaris. J Invest Dermatol 1974, 62:37-41
7. Webster G, Leyden J: Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980, 4:261-269
8. Vowels B, Yang S, Leyden J: Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 1995, 63:3158-3165
9. Tsao S, Dover J, Arndt K, Kaminer M: Scar management: keloid, hypertrophic, atrophic, and acne scars. Semin Cutan Med Surg 2002, 21:46-75
10. Hirsch R, Lewis A: Treatment of acne scarring. Semin Cutan Med Surg 2001, 20:190-198
11. Leyden J, McGinley L, Cavalieri S, Webster G, Mills O, Kligman A: Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983, 8:41-45
12. Eady E, Jones C, Tipper J, Cove J, Cunliffe W, Layton A: Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ 1993, 306:555-556
13. Eady E, Cove J, Blake J, Holland K, Cunliffe W: Recalcitrant acne vulgaris: clinical, biochemical, and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988, 118:415-423
14. Peck G, Olsen T, Yoder F, Strauss J, Downing D, Pandya M, Butkus D, Arnaud-Battndier J: Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med 1979, 300:329-333
15. Strauss J, Rapini R, Shalita A, Konecky E, Pochi P, Comite H, Exner J: Isotretinoin therapy for acne: results of a multicenter dose-response study. J Am Acad Dermatol 1984, 10:490-496
16. Wysowski D, Pitts M, Beitz J: Depression and suicide in patients treated with isotretinoin. N Engl J Med 2001, 344:460
17. Jick S, Kremers H, Vasilakis-Scaramozza C: Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000, 136:1231-1236
18. Fisher G, Datta S, Talwar H, Wang Z, Varani J, Kang S, Voorhees J: Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996, 379:335-339
19. Galis Z, Sukhova G, Libby P: Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995, 9:974-980
20. Fligiel S, Varani J, Datta S, Kang S, Fisher G, Voorhees J: Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol 2003, 120:842-848
21. Bank R, Krikken M, Beekman B, Stoop R, Maraudas A, Lafeber F, Koppele J: A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 1997, 16:233-243
22. Yamamoto Y, Gaynor R: Role of the NFκB pathway in the pathogenesis of human disease states. Curr Mol Med 2001, 1:287-296
23. Boone D, Lee E, Libby S, Gibson P, Chien M, Chan F, Madonia M, Burkett P, Ma A: Recent advances in understanding NFκB regulation. Inflamm Bowel Dis 2002, 8:201-212
24. Fisher G, Talwar H, Lin J, Lin P, McPhillips F, Wang Z, Li X, Wan Y, Kang S, Voorhees J: Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 1998, 101:1432-1440
25. Angel P, Karin M: Specific members of the Jun protein family regulate collagenase expression in response to various extracellular stimuli. Matrix Suppl 1992, 1:156-164
26. Crowe D, Tsang K, Shemirani B: Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. Neoplasia 2001, 3:27-32
27. Birkedal-Hansen H, Moore W, Bodden M, Windsor L, Birkedal-Hansen B, DeCarlo A, Engler J: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250
28. Hirose T, Patterson C, Pourmotabbed T, Mainardi C, Hasty K: Structure-function relationship of human neutrophil collagenase: identification of regions responsible for substrate specificity and general proteinase activity. Proc Natl Acad Sci 1993, 90:2569-2573
29. Collins T, Read M, Neish A, Whitley M, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules. FASEB J 1995, 9:899-909
30. Ledebur H, Parks T: Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NFκB site and p65 homodimers. J Biol Chem 1995, 270:933-943
31. Jeremy A, Holland D, Roberts S, Thomson K, Cunliffe W: Inflammatory events are involved in acne lesions initiation. J Invest Dermatol 2003, 121:20-27
32. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002, 72:847-855
33. Santana M, Rosenstein Y: What it takes to become an effector T cell. J Cell Physiol 2003, 195:392-401
34. Okura Y, Jee Y, Matsumoto Y: Acquired thymic tolerance to autoimmune encephalomyelitis is associated with activation of peripheral IL-10-producing macrophages/dendritic cells. Int Immunol 2003, 15:437-446
35. Kondo S: The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA-irradiation. J Invest Dermatol Symp Proc 1999, 4:177-183
36. Whitmarsh A, Davis R: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996, 74:589-607
37. Claret F, Hibi M, Dhut S, Toda T, Karin M: A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 1996, 383:453-457
38. Kazama T, Yaoita E, Ito M, Sato Y: Charge-selective permeability of dermo-epidermal junction: tracer studies with cationic and anionic ferratins. J Invest Dermatol 1988, 91:560-565
39. Okubo T, Sano S: Functional aspects of dermo-epidermal junction. Acta Derm Venereol Suppl (Stockh) 1973, 73:121-128